Optimize Your Product Launch in a Multi-Stakeholder Environment

Commercialization and HEOR, Life Sciences, Pharmaceutical,
  • June 20, 2013

Deeper Insights, Healthier Results

Successfully launching a new pharmaceutical product has become increasingly challenging due to the evolving needs of multiple stakeholders. Understanding those needs and effectively bringing your “value” story to each stakeholder accordingly is the key to your success.

Join us for this complimentary webinar and learn about:

  • Stakeholder dependent communication and special focus needs
  • How the stakeholder business approach leads to both centralized and de-centralized needs
  • Additional levels of support specialty products require
  • How to coordinate your launch activity to meet the needs of all the stakeholders, regardless of your company size
  • Our web-based Allumelaunch planning solution through a live demonstration

Quintiles has played a crucial role in providing insight for more than 110 global product launches, and has helped 23 companies enter the U.S. market in the last few years.

Watch now to learn how to optimize your product launch by first understanding and addressing the needs of all your key stakeholders and then organizing all the launch activities.



Troy Hampton, MBA, Senior Director, Global Market Access and Commercialization, Quintiles

Troy has led multiple strategic consulting engagements over the past eight years including pricing and contracting strategy, clinical-commercial convergence, value proposition development, scenario planning, competitive positioning, and launch. He has broad experience across numerous therapeutic areas including rheumatoid arthritis, cardiovascular, MS, hemophilia, ophthalmology, and oncology.

Troy has more than 16 years of Pharmaceutical marketing expertise across all stakeholders (i.e., patients, providers, payers). Prior to joining Quintiles, Troy ran his own consulting company, PointBreak Consulting, dedicated to helping clients solve strategic issues and has worked as a consultant with Campbell Alliance, a management consultancy dedicated to the Pharmaceutical and biotech industry.

Prior to his time at Campbell, Troy held numerous roles in marketing, strategic planning, portfolio management, and business development at companies that are now Valeant, Pfizer and AbbVie.

Who Should Attend?

Senior level executives from pharma/biotech companies involved in late stage drug development.

Relevant areas:

  • Sales, marketing & commercialization
  • New product planning
  • Strategic planning
  • Finance
  • Business Development
  • Market Access
  • Managed Markets

Xtalks Partners


Quintiles is the only fully integrated bioPharmaceutical services company offering comprehensive solutions worldwide across the product lifecycle. Our network of more than 27,000 professionals in 100 countries has an eye on the future while delivering results today with an unwavering commitment to patients, safety and ethics. Quintiles helps bioPharmaceutical companies develop and commercialize products to improve and lengthen patients’ lives while demonstrating value to stakeholders.

As a pioneer in bioPharmaceutical services, Quintiles has helped develop or commercialize all of the top 50 best-selling drugs during our 30 years of experience. We have supported over 80 product launches in the US, including 25 companies who were launching a product for the first time. The benefits of our partnership model include retention of strategic control, long term value maximization, operational risk management, and corporate and operational flexibility, and hence offers an attractive alternative to traditional co-promotion and out-licensing approaches.

Media Partners

Related Webinars

Sign Up To Register for this Webinar

Interested in this webinar? Signup to learn more and register for upcoming webinars or recorded webinars.

Sign Up